InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (18 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
18
T+90 hit rate
0%
T+90 mean return
-1.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Morningside Venture Investments Ltd. Officer active across 5 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 34 filings have been logged. Split: 3 buys · 18 sells. Total volume traded: €36.6m. Activity tracked since 18 November 2021. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Morningside Venture Investments Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
312,500 shares@ US$16.000.40% mcap82.1% of flowCommon StockSEC:0000905148-26-003483:3
Canonical exit: 1 Nov 2026 (T+90)
75,624 shares@ US$14.400.086% mcap17.9% of flowClass A Common StockSEC:0000905148-26-003483:4
6,840,213 sharesClass A Common StockSEC:0000905148-26-003483:0
6,840,213 sharesClass A Common StockSEC:0000905148-26-003483:1
75,624 sharesClass A Common StockSEC:0000905148-26-003483:5
75,624 sharesCommon StockSEC:0000905148-26-003483:6
6,840,213 sharesCommon StockSEC:0000905148-26-003483:2
3,500,000 shares0Common StockSEC:0000950170-23-043301:0
2,000,000 shares0Common StockSEC:0000899243-23-018211:0
16,919,155 sharesCommon StockSEC:0000950170-23-034397:0
29,048 shares@ US$30.458.3% of flowCommon StockSEC:0000899243-23-010078:0
32,964 shares@ US$30.259.4% of flowCommon StockSEC:0000899243-23-009972:0
34,641 shares@ US$31.6910.4% of flowCommon StockSEC:0000899243-23-009506:0
9,122 shares@ US$32.552.9% of flowCommon StockSEC:0000899243-23-008858:0
70,714 shares@ US$34.5423.2% of flowCommon StockSEC:0000899243-23-008733:0
50,000 shares@ US$33.7516.1% of flowCommon StockSEC:0000899243-23-007120:0
47,888 shares@ US$34.7015.9% of flowCommon StockSEC:0000899243-23-006394:0
39,916 shares@ US$35.9113.7% of flowCommon StockSEC:0000899243-23-006123:0
25,000 shares@ US$7.1468.2% of flowCommon StockSEC:0000899243-23-004187:0
40,000 shares@ US$6.9512.8% of flowCommon StockSEC:0000899243-23-003869:0
30,000 shares@ US$6.919.5% of flowCommon StockSEC:0000899243-23-003120:0
50,000 shares@ US$6.8515.7% of flowCommon StockSEC:0000899243-23-002854:0
80,000 shares@ US$6.8125.1% of flowCommon StockSEC:0000899243-23-002677:0
6,114 shares@ US$6.791.9% of flowCommon StockSEC:0000899243-23-002157:0
5,000 shares@ US$6.771.6% of flowCommon StockSEC:0000899243-23-001846:0
25 of 34 declarations
About Morningside Venture Investments Ltd
Morningside Venture Investments Ltd is a declarant with 27 filings in total. Across the 27 sampled filings, the period runs from 2021-11-18 to 2023-08-17, with EUR 20,464,598 of buys and EUR 11,807,162 of sells, and the most frequent transaction nature is sale. The companies mentioned are Kezar Life Sciences, Inc., Amylyx Pharmaceuticals, Inc., GreenLight Biosciences Holdings, PBC, and Apellis Pharmaceuticals, Inc.
